Based upon news this morning, we could be experimenting a fantastic leg up for SSS.
No major resistance in sight (at least before 0,45) and good share pirce increase this morning with relatively mid range volume.
IF volume was to pick up a bit more, i expect a return to over 0,50 this week and within the next 4 weeks share price could be over 0,75 awaiting news from their latest Phase 11B and based upon wording from SSS in their news release, the tone of it makes me believe it could be really good as they did not used the usual formal text to announce the end of their phase 2b.
quote:
This exhilarating period in the Company's development is the culmination of solid support from the Company's shareholders, management and research and development team. SCT looks forward with great anticipation to the soon to be announced top-line results of the modified REGENESIS- trial as this truly marks a key milestone in the development of this new therapy for stroke patients. With enrollment of the modified Phase IIb stroke trial ended and data analysis commencing top-line results are expected within the next 4 weeks, significantly earlier than the "end of Q2" target that we previously discussed."
end quote.
It is more enthousiatic than before telling me to read between the lines.
In any case, SSS should be play safely meaning that if you bought on dips and sold also on momentum, your cost should be close to 0,20. So, if you can get your cost to almost 0 then whatever is left will be on the house.
If that trial was to be conclusive, expect many great company to knock on their door for a join venture and from there, the share price would explode. Remember that their share float is only 134M shares. Not really high for a pharma research company.
Their management is rated 4 stars by morningstar and without a doubt this is one of my great picks for this year.
As usual, be reponsible, do not bet the barn on only 1 stock and do not invest more than you can afford to loose.
Aucun commentaire:
Publier un commentaire